baber/WOPTO huggingface dataset:
Patent DE-602004002821-T2 (DE)
Inventor: VINCENT PHILIPPE
IPC: B60H1/00
Filed: 2004-08-11
Granted: 2007-08-23
Abstract: The device has an air mixing chamber (7) communicating with hot and cold air flow supply conduits (4,5) and with two air flow distribution conduits (2,3) connected with air distribution openings. A control unit has two valves (8,9) equipped with respective blocking walls (10,11) to manage access of hot and cold air flow to upstream part (13) of the chamber. A passage (17) forwards a part of the air flow towards the chamber.
Patent DE-602004003494-T2 (DE)
Inventor: LAPORTE NEOVE
IPC: B65F1/14
Filed: 2004-05-13
Granted: 2007-10-04
Abstract: A refuse bin comprises a refuse container ( 10 ) having a top opening ( 12 ) and a lid ( 14 ) hinged relative to the container to cover the opening. A compacting mechanism is fitted to the lid and comprises a compacting plate ( 22 ) mounted under the lid and an actuating rod ( 24 ) coupled to the compacting plate through an aperture ( 26 ) in the lid. The coupling is such that the rod ( 24 ) may be maneuvered from a storage position wherein the rod lies across the top surface of the lid and the plate is drawn up under the lid to an operative position wherein the rod stands upright over the aperture in the lid and may be pushed downwardly through the aperture to push the plate down into the container. The compacting mechanism further comprises a ratchet mechanism ( 50, 52, 54 ) for releasably locking the actuating rod ( 24 ) against movement upwardly through the aperture in the lid such that refuse in the container can be compacted by force applied to an edge ( 48 ) of the lid opposite the hinge.
Patent DE-602004004796-T2 (DE)
Inventor: WINDISCH JOERG
IPC: C07K14/56
Filed: 2004-08-12
Granted: 2007-12-06
Abstract: The present invention relates to an expression vector, comprising a polynucleotide encoding a fusion protein comprising the signal sequence of the gac gene of Pseudomonas diminuta and a polypeptide of interest, a prokaryotic host cell transformed with such an expression vector and a process for production of a polypeptide of interest using said host cell and said expression vector.
Patent DE-602004004929-T2 (DE)
Inventor: DAVIES OLIVER
IPC: G06F19/00
Filed: 2004-10-29
Granted: 2007-10-31
Abstract: The present invention is directed to a method of reducing the effects of interfering compounds in the measurement of analytes and more particularly to a method of reducing the effects of interfering compounds in a system wherein the test strip utilizes two or more working electrodes. In one embodiment of the present invention, a first potential is applied to a first working electrode and a second potential, having the same polarity but a greater magnitude than the first potential, is applied to a second working electrode.
Patent DE-602004009651-T2 (DE)
Inventor: BOUET EMMANUEL
IPC: H02B1/46
Filed: 2004-07-13
Granted: 2008-02-21
Abstract: The device has a case defining an inner space to receive electrical units, and a cover connected to the case to close the space. A partition in a shaft delimits a guiding chamber inserting and maintaining a quarter turn type fixing unit (S1) having a locking unit (32). The partition has an opening for receiving the locking unit, where the opening is contiguous with a retention flange for locking the locking unit to close the cover.
Patent DE-602005004904-T2 (DE)
Inventor: LOH KUM CHUNG
IPC: G11B17/028
Filed: 2005-03-21
Granted: 2009-02-26
Abstract: A turntable for an optical storage drive comprises a fitting member (4) consisting of a stationary yoke and a movable yoke (40) carrying a sliding cam (40a). A plurality of inwardly directed, equally spaced, resiliently deformable fingers (12) extend from a disc setting surface (3) at a location radially inward from the periphery of the turntable. In the rest position, there is no contact between the sliding cam (40a) and the fingers (12). However, after a disc (101) has been positioned on the turntable, the movable yoke is lifted and the sliding cam (40a) provides a locking effect on the fingers (12), thereby improving the centering force thereof.
Patent DE-69118880-T3 (DE)
Inventor: GASCO MARIA ROSA
IPC: A61K9/51
Filed: 1991-08-05
Granted: 2003-05-08
Abstract: Solid lipid microspheres having a diameter lower than one micron and a polydispersion of between 0.06 and 0.90 obtained by adding to a molten lipid substance a mixture consisting of water, a surfactant and possibly a co-surfactant, dispersing in water the obtained microemulsion, washing with water the dispersion microspheres by diafiltration and lyophilizing.
Patent DE-69504773-T3 (DE)
Inventor: STREIT BERNARD
IPC: H02G9/06
Filed: 1995-05-03
Granted: 2004-02-12
Abstract: The protective sheath has at regular intervals (d) on its exterior surface a gap (14) whose width is greater than the gap width (10) between successive ribs (12) on the sheath wall. A fixing clip (20) associated with the sheath, has on its internal face (20), surrounding the sheath, a rib (26) which is designed to fit into the gap (14). <IMAGE>
Patent DK-1054362-T3 (DK)
Inventor: KAYANI SOHAIL
IPC: G07D7/182
Filed: 1997-10-10
Granted: 2002-09-02
Abstract: Measuring the limpness of a note is necessary to separate a worn note out of circulation. A method of measuring the limpness of a note is disclosed which measures the heat capacity of the note.
Patent DK-1106339-T3 (DK)
Inventor: TOTANI MIKIO
IPC: B31B37/00
Filed: 2000-12-01
Granted: 2007-01-29
Abstract: A plastic bag is provided in which the layers of panel portion (2a, 2b) are heat sealed with the layers of bottom gusset portion (18a, 18b) along the bottom edges (10) respectively so that the bottom edges are connected with each other by the.bottom gusset portion. The layers of first and second auxiliary gusset portions (22a, 24a) are heat sealed with the layers of first and second side gusset portions (12a, 12b, 14a, 14b) along the bottom edges respectively so that the first and second side gusset portions are connected with the bottom gusset portion by the first and second auxiliary gusset portions. In addition, the layers of panel portion are heat sealed with the layers of first and second side gusset portions along the first and second side edges (6, 8) respectively so that the first side edges are connected with each other by the first side gusset portion, the second side edges being connected with each other by the second side gusset portion. The bottom gusset portion and the first and second auxiliary gusset portions invade the ranges of seal width of the layers of panel portion with the layers of first and second side gusset portions. <IMAGE>
Patent DK-1200385-T3 (DK)
Inventor: PFLAUM ZLATKO
IPC: A61K31/22
Filed: 2000-08-04
Granted: 2005-05-23
Abstract: Lovastatin, pravastatin, simvastatin, mevastatin, atorvastatin, fluvastatin and cervastatin and derivatives and analogs thereof are known as HMG-CoA reductase inhibitors and are used as antihypercholesterolemic agents. The majority of them are produced by fermentation using microorganisms of different species identified as species belonging to Aspergillus, Monascus, Nocardia, Amycolatopsis, Mucor or Penicillium genus, some are obtained by treating the fermentation products using the methods of chemical synthesis (simvastatin) or they are the products of total chemical synthesis (fluvastatin, atorvastatin and cervastatin). The present invention relates to a crystalline form of the sodium salt of pravastatin, which is known by the chemical name 1-naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, mono sodium salt, which is useful as a pharmaceutical substance. The present invention further relates to the method for its preparation and isolation, to a pharmaceutical formulation containing the sodium salt of pravastatin in the crystalline form and a pharmaceutically acceptable carrier, and to a pharmaceutical method of treatment. The novel crystalline form of the sodium salt of pravastatin is useful in the treatment of hypercholesterolemia and hyperlipidemia.
Patent DK-1210425-T3 (DK)
Inventor: BROWNING JEFFREY
IPC: C07K19/00
Filed: 2000-08-16
Granted: 2007-09-17
Abstract: A receptor in the TNF family is provided: BAFF-R. Chimeric molecules and antibodies to BAFF-R and methods of use thereof are also provided.
Patent DK-1232489-T3 (DK)
Inventor: PREIKSZAS KAI-UWE
IPC: G01N/
Filed: 2000-11-14
Granted: 2003-12-15
Abstract: The invention relates to a detector for scattered light, especially for detecting particles in a carrier medium. Said detector comprises a housing (1) and an inlet (3) and an outlet (5) in the housing (1). The carrier medium flows through the housing between said inlet and outlet and on a flow path (7). The inventive detector also comprises a light source (9) that directs light to a scattered light centre (11) which lies on the flow path (7). The inventive detector further comprises a receiver (13) for a portion of the light which is scattered onto particles in the scattered light centre (15) and a light trap (15) for light which is not scattered in the scattered light centre (11). The aim of the invention is to improve such a detector for scattered light in such a way that compact construction and high responsiveness are guaranteed. The light trap (15) can be embodied in two ways. According to a first embodiment, the light source (9) is arranged outside the flow path (7) and the centre axis (18) of the light cone (20) pertaining to the light source (9) extends at least partially parallel in relation to or on the centre line (58) of the flow path (7). The light trap (15) allocated to the light source (9) is part of the flow channel guiding the flow path (7). According to a second embodiment, the receiver (13) is arranged outside the flow path (7). The axis (14) of the receiver extends at least partially parallel in relation to or on the centre line (58) pertaining to the flow path (7). The light trap (23) allocated to the receiver (13) is part of the flow channel guiding the flow path (7).
Patent DK-1149774-T3 (DK)
Inventor: BRAKEMANN JOERG
IPC: B65D81/05
Filed: 2001-04-07
Granted: 2004-09-27
Abstract: In a packaging arrangement for light but delicate items such as a notebook computer, the item is secured by secondary packaging within e.g. an outer carton. The secondary packaging consists of a carrying section (1) with a flat carton rest surface (2), partly surrounded by a plastics foil bag (4).
Patent DK-1152012-T3 (DK)
Inventor: LALVANI AJIT
IPC: C12N5/0783
Filed: 1997-11-25
Granted: 2007-11-26
Abstract: The present invention relates to the identification of CD8<+> T cell epitopes in the ESAT-6 protein of Mycobacterium tuberculosis and the use of peptides containing such epitopes in the provision of vaccines.
Patent DK-1270734-T3 (DK)
Inventor: BRUNNER KARLHEINZ DR
IPC: C12M1/33
Filed: 2001-06-21
Granted: 2008-05-05
Abstract: Process (I) for the enzymatic hydrolysis of oils and fats to produce fatty acids and glycerol by contacting a mixture of the oil or fat and water with lipase biocatalyst comprises: (a) carrying out the hydrolysis reaction until the reaction rate falls below a preset value; (b) separating the aqueous glycerol phase; (c) separating the fatty acids from the organic phase; and (d) recycling the rest of the organic phase. Independent claims are also included for: (1) a process (II) for the enzymatic hydrolysis of oils and fats to produce fatty acids and glycerol by contacting a mixture of the oil or fat and water with a lipase biocatalyst, comprising: (a) separating the hydrolysis reaction mixture into an aqueous glycerol phase and an organic phase in a self-discharging separator operated so that a lipase-enriched layer collects between the aqueous and organic phases in the plate stack of the separator; (b) emptying the separator at preset times; and (c) recycling the discharged contents of the separator drum; and (2) a process (III) for the enzymatic hydrolysis of oils and fats to produce fatty acids and glycerol by contacting a mixture of the oil or fat and water with a lipase biocatalyst, comprising carrying out the hydrolysis discontinuously in multiple parallel reactors operating in a loop system, with pumped recirculation of the reactor contents so that one reactor is being filled with oil or fat while another is in hydrolysis service, and another is being emptied into a separator which separated the aqueous glycerol phase from the organic phase before the fatty acids are separated from the organic phase.
Patent DK-1134238-T3 (DK)
Inventor: HOWARD PHILIP
IPC: C08F10/02
Filed: 1995-03-28
Granted: 2005-11-28
Abstract: Copolymers of ethylene and an alpha-olefin having from 3 to 20 carbon atoms are characterised in having   (a) a flow activation energy (Ea) in the range 50 ≤ Ea ≤ 200 kJ/mol, (b) a degree of long chain branching (LCB/1000C) as measured by GPC/solution viscometry in the range <DF>LCB ≤ 0.03 Ea - 1.5 to LCB ≥ 0.25, </DF> and (c) a breadth of molecular weight distribution (Mw/Mn) greater than 2.5.   The novel copolymers may be used to prepare films.
Patent DK-1282775-T3 (DK)
Inventor: WOBBEN ALOYS
IPC: F03D11/00
Filed: 2001-03-02
Granted: 2005-04-04
Abstract: The energy generation plant has a device for continuous discharge of electrostatic charge from each rotor blade (5) of the wind turbine rotor, provided by a series ohmic resistance and an inductance, connected between the rotor blade and earth. The electrostatic charge discharging device can be connected in parallel with the lightning protection system for the energy generation plant.
Patent DK-1210286-T3 (DK)
Inventor: TARTARA GIAMPIERO
IPC: B62D7/08
Filed: 2001-04-17
Granted: 2008-02-04
Abstract: A forklift truck with reduced turning radius is equipped with: a frame (2); two front drive wheels (3a, 3b) that turn about a common axis of rotation (A) transversal to a longitudinal central plane (M) of the forklift truck (1) itself; a rear axle (14) supporting two back wheel mounting forks (10) which rotate about respective second axes (12) substantially parallel to the central plane (M) and mounting in turn two steerable back wheels (4a, 4b); a steering device (26) designed to coordinate the rotation of the mounting forks (10) about the respective second axes (12) in such a way that the centre at full lock is positioned at the point where the first axis (A) intersects the central plane (M); and a rear counterweight (35). The axle (14), the mounting forks (10) and the steering device (26) form a unit (33) which can be pre-assembled and which is supported directly by a back end (36) of the frame (2), which also directly supports the counterweight (35) in a position in which the unit (33) is located between the back end (36) and the counterweight (35) itself. The frame (2) has a rear opening (34) providing access to the steering device (26).
Patent DK-1241183-T3 (DK)
Inventor: WOOD WILLIAM I
IPC: C12N15/12
Filed: 1999-03-08
Granted: 2008-12-01
Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Patent DK-1277527-T3 (DK)
IPC: B09B3/00
Filed: 2002-07-17
Granted: 2009-06-29
Abstract: The method of converting asbestos cement products such as waste into asbestos free cement products involves placing the initial product as pieces in a tunnel oven at a preset temperature of between  six hundred and one thousand degrees for drying the asbestos fibres. This is followed by mechanical comminuting to produce a secondary raw material without asbestos for the cement industry .
Patent DK-1353691-T3 (DK)
Inventor: RENNER WOLFGANG A
IPC: A61K38/095
Filed: 2002-01-21
Granted: 2009-04-20
Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array. The invention also provides a process for producing an antigen or antigenic determinant in an ordered and repetitive array. The ordered and repetitive antigen or antigenic determinant is useful in the production of vaccines for the treatment of infectious diseases, the treatment of allergies and as a pharmaccine to prevent or cure cancer and to efficiently induce self-specific immune responses, in particular antibody responses.
Patent DK-1379289-T3 (DK)
Inventor: SOHIER JEROME
IPC: A61F2/82
Filed: 2002-04-02
Granted: 2005-05-02
Abstract: Coating for medical device comprises a copolymer of a polyalkylene glycol terephthalate and an aromatic polyester. An independent claim is also included for a method for applying a coating to a surface, which comprises brushing, spraying, wiping, dipping, extruding, or injecting.
Patent DK-1438013-T3 (DK)
Inventor: AMARI SERGIO
IPC: C09K23/00
Filed: 2002-10-16
Granted: 2012-08-20
Abstract: The present invention relates to a natural ethylene oxide-free emulsifier composed of olive oil, the fatty acid of which have been esterified, preferably with sorbitol and/or cetyl stearyl alcohol. The present invention also relates to cosmetics containing, as an emulsifier, an emulsifier as described above, as well as a method for manufacturing such a product for cosmetic use.
Patent DK-1477648-T3 (DK)
Inventor: RICORDI CHRISTIAN PAUL A
IPC: F02B63/02
Filed: 2004-04-29
Granted: 2006-11-20
Abstract: A combustion tool employing a replaceable pressurized fuel cell (14) includes a fuel condition monitor system (30) for monitoring and indicating fuel cell fuel condition. The fuel condition monitor system (30) includes a fuel condition monitor (32) for monitoring at least one of fuel cell pressure and fuel flow from the fuel cell (14), a control unit (42) connected to the monitor (32) for receiving fuel condition data sensed by the monitor (32), comparing the sensed data with preset values and determining fuel level in the fuel cell (14) based on the determinations, a metering valve (12) connected to the control unit (42), providing the exact amount of fuel based upon fuel cell condition, and an indicator (44) connected to the control unit for providing an indication of fuel level. A method of monitoring and indicating combustion tool fuel cell condition includes providing a preset series of fuel cell condition values, monitoring fuel cell condition, obtaining fuel cell condition data, comparing the monitored data with preset values and determining whether there is sufficient fuel and providing a signal to an indicator. <IMAGE>
Patent DK-1622879-T3 (DK)
Inventor: MIZUNO HAJIME
IPC: C07D239/34
Filed: 2004-05-10
Granted: 2011-05-23
Abstract: The present invention relates to a pyrimidine compound of the formula (II′): wherein R1 represents a hydrogen atom, halogen atom or C1-C4 alkyl; R3 represents a hydrogen atom, halogen atom or C1-C3 alkyl; X3 represents C5 polymethylene, in which a single CH2—CH2 may be replaced with a single CH═CH, substituted with at least one substituent selected from the group consisting of halogen atoms, trifluoromethyl and C1-C4 alkyls.
Patent DK-1663963-T3 (DK)
Inventor: REBIERE FRANCOIS
IPC: C07C327/28
Filed: 2004-09-17
Granted: 2007-10-29
Abstract: The invention relates to a method for preparing a sulphoxide compound of formula (I) either as a single enantiomer or in an enantiomerically enriched form, comprising the steps of :  a) contacting a pro-chiral sulphide of formula (II) with a metal chiral complex, a base and an oxidizing agent in an organic solvent ; and optionally b) isolating the obtained sulphoxide of formula (I). <CHEM>  wherein n, Y, R1, R1a, R2 and R2a are as defined in claim 1.
Patent DK-1718328-T3 (DK)
Inventor: INBAL AIDA
IPC: A61K38/45
Filed: 2005-02-15
Granted: 2009-07-27
Abstract: Subject of the present invention is the use of a Factor XIII-preparation preferably in injectable form for the treatment of diseases which are associated with disturbed blood perfusion of the tissue following transient or permanent ischemia.
Patent DK-1732886-T3 (DK)
Inventor: STIMAC ANTON
IPC: C07D207/34
Filed: 2005-04-08
Granted: 2010-06-14
Abstract: The invention relates to crystalline forms and 1 and 2 of atorvastatin tert.-butyl ester (Formula (II)), processes for their preparation and their conversion to highly pure atorvastatin hemi calcium in non-crystalline, in particular amorphous form.
Patent DK-1740643-T3 (DK)
Inventor: MAENNLE FERDINAND
IPC: C08G/
Filed: 2005-04-15
Granted: 2011-07-18
Abstract: Polybranched, particulate, organic/inorganic hybrid polymer in the form of a sol-gel product having the basic structure: Formula (I) where X is a linkage group chosen among C1-C18-alkylene and arylene, R1-R6 are chosen among hydrogen, C1-C18-alkyl, aryl, formyl, aliphatic or aromatic carbonyl, carbamoyl, sulphonyl, sulphoxyl, phosfonyl, sulphinyl or phosphinyl, or R1-R6 are chosen among condensation products and addition products of acids, alcohols, phenoles, amines, aldehydes or epoxides.
Patent DK-1824479-T3 (DK)
Inventor: FEENSTRA ROELOF W
IPC: A61K31/423
Filed: 2005-12-06
Granted: 2009-03-09
Abstract: The invention relates to a group of novel phenylpiperazine derivatives with a dual mode of action: serotonin reuptake inhibition and partial agonism on dopamine -D2 receptors. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. The compounds have the general formula (1) wherein the symbols have the meanings given in the specification.
Patent DK-1879901-T3 (DK)
Inventor: GREGSON STEPHEN J
IPC: A61K31/5517
Filed: 2006-04-21
Granted: 2010-05-03
Abstract: Compounds of the formula I: or solvate thereof, wherein: R2 is an optionally substituted C5-20 aryl group; R6 and R9 are independently selected from H, R, OH, OR, SH, SR, NH2, NHR, NRR', nitro, Me3Sn and halo; where R and R' are independently selected from optionally substituted C1-12 alkyl, C3-20 heterocyclyl and C5-20 aryl groups; R7 is selected from H, R, OH, OR, SH, SR, NH2, NHR, NHRR', nitro, Me3Sn and halo; R'' is a C3-12 alkylene group, which chain may be interrupted by one or more heteroatoms and/or aromatic rings; X is selected from O, S, or NH; z is 2 or 3; M is a monovalent pharmaceutically acceptable cation; R2', R6', R7', R9', X' and M' are selected from the same groups as R2, R6, R7, R9, X and M respectively, or M and M' may together represent a divalent pharmaceutically acceptable cation.
Patent DK-2000474-T3 (DK)
Inventor: KAJIHARA YASUHIRO
IPC: C07K9/00
Filed: 2007-03-28
Granted: 2018-01-22
Abstract: The present invention provides a process for producing a peptide thioester compound,  characterized by  comprising: (A) forming a peptide by a solid-phase synthesis method using a resin modified with a linker represented by the formula (1) as a solid phase; (B) cleaving a bond between the solid phase and the peptide with at least one acid selected from dilute hydrochloric acid, dilute sulfuric acid, formic acid, and acetic acid to produce a peptide having a carboxyl group at the C-terminus; and (C) reacting a thiol compound with the peptide at -100 to 0°C in the presence of a condensing agent in a solvent: (1) wherein R 1  represents C 1-4  alkyl group, R 2  represents hydrogen atom or C 1-4  alkoxy group, and n represents an integer of 1 to 4.
Patent DK-2066786-T3 (DK)
Inventor: SASAI YOSHIKI
IPC: C12N5/22
Filed: 2007-09-24
Granted: 2018-07-23
Abstract: Stem cells such as embryonic stem cells (ES cells), including human ES cells, are cultured in a medium comprising a ROCK inhibitor, and a stem cell culture medium, optionally serum free, comprises a ROCK inhibitor.